Detalhe da pesquisa
1.
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.
N Engl J Med
; 383(1): 35-48, 2020 07 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32579807
2.
Relative bioavailability of budesonide/glycopyrrolate/formoterol fumarate triple therapy delivered using next generation propellants with low global warming potential.
Pulm Pharmacol Ther
; 83: 102245, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37607661
3.
Relationship between risk, cumulative burden of exacerbations and mortality in patients with COPD: modelling analysis using data from the ETHOS study.
BMC Med Res Methodol
; 22(1): 150, 2022 05 25.
Artigo
Inglês
| MEDLINE | ID: mdl-35614467
4.
Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study.
Am J Respir Crit Care Med
; 203(5): 553-564, 2021 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33252985
5.
A scintigraphy study of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in patients with moderate-to-very severe chronic obstructive pulmonary disease.
Respir Res
; 22(1): 261, 2021 Oct 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34620167
6.
Functional respiratory imaging assessment of budesonide/glycopyrrolate/formoterol fumarate and glycopyrrolate/formoterol fumarate metered dose inhalers in patients with COPD: the value of inhaled corticosteroids.
Respir Res
; 22(1): 191, 2021 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34210340
7.
Comparison of autoinjector with accessorized prefilled syringe for benralizumab pharmacokinetic exposure: AMES trial results.
J Asthma
; 58(1): 93-101, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31539289
8.
Efficacy and safety of benralizumab in Japanese patients with severe, uncontrolled eosinophilic asthma.
Allergol Int
; 67(2): 266-272, 2018 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-29128192
9.
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting ß2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial.
Lancet
; 388(10056): 2115-2127, 2016 10 29.
Artigo
Inglês
| MEDLINE | ID: mdl-27609408
10.
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial.
Lancet
; 388(10056): 2128-2141, 2016 10 29.
Artigo
Inglês
| MEDLINE | ID: mdl-27609406
11.
A nonsteroidal glucocorticoid receptor agonist inhibits allergen-induced late asthmatic responses.
Am J Respir Crit Care Med
; 191(2): 161-7, 2015 Jan 15.
Artigo
Inglês
| MEDLINE | ID: mdl-25473939
12.
Effect of inhaled budesonide/formoterol fumarate dihydrate delivered via two different devices on lung function in patients with COPD and low peak inspiratory flow.
Ther Adv Respir Dis
; 16: 17534666221107312, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35815354
13.
Safety, Pharmacokinetics and Pharmacodynamics of the Selective Glucocorticoid Receptor Modulator Velsecorat (AZD7594) Following Inhalation in Healthy Volunteers.
Drug Des Devel Ther
; 16: 485-497, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35264846
14.
Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOS.
Int J Chron Obstruct Pulmon Dis
; 17: 3061-3073, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36510486
15.
Swedish translation and validation of the Pediatric Allergic Disease Quality of Life Questionnaire (PADQLQ).
Acta Paediatr
; 100(2): 242-7, 2011 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-20874810
16.
Benefits of budesonide/glycopyrrolate/formoterol fumarate (BGF) on symptoms and quality of life in patients with COPD in the ETHOS trial.
Respir Med
; 185: 106509, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34171789
17.
Improvements in lung function with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler versus dual therapies in patients with COPD: a sub-study of the ETHOS trial.
Ther Adv Respir Dis
; 15: 17534666211034329, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34428980
18.
Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Exacerbation Outcomes in Patients with COPD without a Recent Exacerbation History: A Subgroup Analysis of KRONOS.
Int J Chron Obstruct Pulmon Dis
; 16: 179-189, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33542624
19.
Pulmonary deposition of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler formulated using co-suspension delivery technology in healthy male subjects.
Eur J Pharm Sci
; 153: 105472, 2020 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32682074
20.
Single-Use Autoinjector Functionality And Reliability For At-Home Administration Of Benralizumab For Patients With Severe Asthma: GRECO Trial Results.
J Asthma Allergy
; 12: 363-373, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31695439